Singapore biotech firm Austrianova secures US$100M investment

Austrianova, a Singapore-based biotech company, has signed an agreement with Luxumbourg-based private alternative investment group GEM Global Yield to provide it with a share subscription facility of up to US$100 million for a 36-month term, following a public listing. The deal will allow Austrianova to draw down funds by issuing shares of common stock to GEM. Austrianova will control the timing…
« Previous post: | Next post: »